Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
Alzheimers Res Ther
.
2023 Jan 21;15(1):18.
doi: 10.1186/s13195-022-01156-8.
Authors
Jacqui T Nimmo
1
,
Ajay Verma
2
,
Jean-Cosme Dodart
2
,
Chang Yi Wang
2
,
Jimmy Savistchenko
3
,
Ronald Melki
3
,
Roxana O Carare
1
,
James A R Nicoll
4
Affiliations
1
Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
2
United Neuroscience, Dublin, Republic of Ireland.
3
Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Paris, France.
4
Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. J.Nicoll@soton.ac.uk.
PMID:
36681823
PMCID:
PMC9863168
DOI:
10.1186/s13195-022-01156-8
No abstract available
Publication types
Published Erratum